Segment & Geographic Data
Quant-Grade Normalized (live API)
API & CSV Delivery
Edap Tms Sa's Business Segments
Edap Tms Sa's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Segment Data As of Q2 FY2026
Reportable Segments
-
Largest Segment
-
Total Revenue
$ 13
Regions Reported
1
Edap Tms Sa does not report a distinct business-segment axis in its filings - its disaggregated revenue is disclosed by product and service category instead. See the Product & Service breakdown below.
Revenue Share by Region - Q2 FY2026
- Asia0.9%
Revenue by Geographic Region - Q2 FY2026
| Region | Revenue (Millions) | % of Total |
|---|---|---|
| Asia | $ 0 | 0.9% |
Revenue by Product & Service Category - Q2 FY2026
- Product and Service100%
- Manufactured Product Other72.2%
- HIFU Treatments and Devices Leased20.9%
- Parts and Services7%
Revenue by Product & Service Category - Q2 FY2026
| Category | Revenue (Millions) | % of Total |
|---|---|---|
| Product and Service | $ 13 | 100% |
| Manufactured Product Other | $ 10 | 72.2% |
| HIFU Treatments and Devices Leased | $ 3 | 20.9% |
Product and service categories are a supplemental disclosure and are not required to sum to consolidated revenue or to the reportable segments above.
1 more categories available
Sign in to unlock the full Edap Tms Sa dataset.
Description of Edap Tms Sa
Edap Tms Sa, also known as EDAP - TMS, is a company that operates in the field of medical technology. Founded in 1979, the company is headquartered in Lyon, France. EDAP - TMS specializes in the development, manufacture, and distribution of innovative medical devices for the treatment of urological conditions, particularly in the field of minimally invasive surgeries.
The company's primary focus is on developing and commercializing high-intensity focused ultrasound (HIFU) devices. HIFU is a non-invasive medical procedure that uses focused ultrasound waves to heat and destroy targeted tissue in the body. EDAP - TMS has become a pioneer in this technology, continually working on improving and expanding its HIFU systems.
EDAP - TMS's flagship product is the Ablatherm® Robotic HIFU, which is used for the treatment of prostate cancer. It is an advanced robotic system that combines real-time imaging and precise robotic control to deliver HIFU energy to the prostate gland with accuracy and efficiency. The Ablatherm® Robotic HIFU has gained significant recognition and is widely used across the world, making EDAP - TMS a global leader in prostate cancer treatment.
In addition to prostate cancer, EDAP - TMS also focuses on treating other urological conditions such as kidney stones and benign prostatic hyperplasia (BPH). The company offers a range of devices for these treatments, including lithotripters for kidney stone fragmentation and HIFU devices for BPH treatment.
Aside from its core products, EDAP - TMS provides various services to support the efficient use of its medical devices. This includes training programs for healthcare professionals, technical support, and ongoing clinical research to further advance the field of HIFU technology. The company's commitment to research and innovation has led to numerous breakthroughs and collaborations with leading medical institutions globally.
EDAP - TMS has a widespread international presence, with subsidiaries and distributors in major markets around the world. The company's products are used in renowned hospitals and medical centers, enabling patients to access cutting-edge treatments for urological conditions.
Overall, EDAP - TMS is a prominent player in the medical technology field, particularly in the area of HIFU treatment for urological conditions. With its innovative products, commitment to research, and global reach, the company continues to make significant contributions to improving patient outcomes in the field of urology.
The company's primary focus is on developing and commercializing high-intensity focused ultrasound (HIFU) devices. HIFU is a non-invasive medical procedure that uses focused ultrasound waves to heat and destroy targeted tissue in the body. EDAP - TMS has become a pioneer in this technology, continually working on improving and expanding its HIFU systems.
EDAP - TMS's flagship product is the Ablatherm® Robotic HIFU, which is used for the treatment of prostate cancer. It is an advanced robotic system that combines real-time imaging and precise robotic control to deliver HIFU energy to the prostate gland with accuracy and efficiency. The Ablatherm® Robotic HIFU has gained significant recognition and is widely used across the world, making EDAP - TMS a global leader in prostate cancer treatment.
In addition to prostate cancer, EDAP - TMS also focuses on treating other urological conditions such as kidney stones and benign prostatic hyperplasia (BPH). The company offers a range of devices for these treatments, including lithotripters for kidney stone fragmentation and HIFU devices for BPH treatment.
Aside from its core products, EDAP - TMS provides various services to support the efficient use of its medical devices. This includes training programs for healthcare professionals, technical support, and ongoing clinical research to further advance the field of HIFU technology. The company's commitment to research and innovation has led to numerous breakthroughs and collaborations with leading medical institutions globally.
EDAP - TMS has a widespread international presence, with subsidiaries and distributors in major markets around the world. The company's products are used in renowned hospitals and medical centers, enabling patients to access cutting-edge treatments for urological conditions.
Overall, EDAP - TMS is a prominent player in the medical technology field, particularly in the area of HIFU treatment for urological conditions. With its innovative products, commitment to research, and global reach, the company continues to make significant contributions to improving patient outcomes in the field of urology.
EDAP TMS SA is a company that specializes in developing and commercializing transformative medical technologies, particularly focused on urology and oncology. Their offerings encompass a wide range of segments, products, and services aimed at improving patient outcomes and enhancing treatment protocols through innovative solutions. Below is an extensive overview of their key segments, products, and services.
Segments
1. Urology
- Focus Area: Urology is a primary segment for EDAP TMS, particularly in the treatment of prostate conditions and cancers. The company emphasizes minimally invasive procedures that improve patient comfort and recovery times.
- Technologies: This segment includes technologies such as high-intensity focused ultrasound (HIFU), which is utilized for the treatment of prostate cancer, offering an alternative to traditional surgical and radiation therapies.
2. Oncology
- Focus Area: EDAP TMS also extends its technological expertise to different types of cancers beyond urology, including liver cancer and other solid tumors. Their solutions aim to provide effective, localized treatment while minimizing collateral damage to surrounding tissues.
- Innovations: The company develops innovative treatment modalities, such as ablative therapies, which are critical in cancer management, offering less invasive options for patients.
3. Research and Development
- Innovation: A significant focus is placed on R&D, where EDAP TMS invests in developing next-generation technologies and therapies that address unmet medical needs in urology and oncology.
- Clinical Trials: Participation in clinical trials to validate new treatments and technologies is a key aspect of their R&D efforts, aimed at increasing the diversity and efficacy of treatment options available to clinicians.
Products
1. HIFU Systems
- Focal One®: A robotic HIFU platform specifically designed for the treatment of localized prostate cancer. This system enables precise targeting of cancerous tissues while preserving surrounding healthy structures.
- Sonablate®: Another HIFU machine tailored for prostate cancer treatment; it allows for real-time imaging and treatment planning, enhancing the overall therapeutic experience for the patient.
2. Erectile Dysfunction Devices
- EDAP TMS offers solutions aimed at addressing erectile dysfunction, which is a common side effect following conventional prostate cancer treatments. Their products focus on restoring functionality and improving quality of life.
3. Surgical Instruments and Accessories
- The company provides a variety of surgical instruments and specialized accessories to support urological procedures, ensuring that healthcare providers have the tools required for optimal patient care.
4. Software Solutions
- Treatment Planning Software: EDAP TMS has developed advanced software solutions to assist in the diagnosis, treatment planning, and follow-up of patients. These tools incorporate imaging and analytics to facilitate personalized treatment strategies.
Services
1. Training and Support
- EDAP TMS offers extensive training services for healthcare professionals on the use of their technologies and systems. This includes operational training, clinical best practices, and ongoing support to ensure effective utilization of their products.
- Workshops and continuous medical education initiatives are also part of their service offerings, aimed at keeping practitioners updated on the latest technologies and treatment protocols.
2. Clinical Support
- The company provides ongoing clinical support to facilities that utilize their technologies, helping clinicians with case management, patient follow-up, and data collection for continuous improvement in care delivery.
3. Warranty and Maintenance Services
- EDAP TMS includes warranty services for their products, along with maintenance contracts to ensure that the equipment remains in optimal condition, thus maximizing operational efficiency and minimizing downtime.
4. Consultative Services
- Consultants at EDAP TMS work with hospitals and clinics to optimize treatment pathways and integrate their technologies into existing practice protocols, further enhancing patient care.
Global Reach and Market Presence
EDAP TMS operates on an international scale, marketing its products and services to hospitals, outpatient centers, and clinics globally. The company engages in strategic partnerships and collaborations to enhance their market presence and extend their product offerings.
Conclusion
EDAP TMS SA is positioned as a pioneering force in the medical technology space, particularly in urology and oncology. Their commitment to research, innovation, and improving patient outcomes is reflected in their extensive range of products and services, which are tailored to meet the evolving needs of healthcare providers and patients alike. By focusing on minimally invasive techniques and advanced technology, EDAP TMS continues to make significant strides in the field of medical treatment and patient care.
Segments
1. Urology
- Focus Area: Urology is a primary segment for EDAP TMS, particularly in the treatment of prostate conditions and cancers. The company emphasizes minimally invasive procedures that improve patient comfort and recovery times.
- Technologies: This segment includes technologies such as high-intensity focused ultrasound (HIFU), which is utilized for the treatment of prostate cancer, offering an alternative to traditional surgical and radiation therapies.
2. Oncology
- Focus Area: EDAP TMS also extends its technological expertise to different types of cancers beyond urology, including liver cancer and other solid tumors. Their solutions aim to provide effective, localized treatment while minimizing collateral damage to surrounding tissues.
- Innovations: The company develops innovative treatment modalities, such as ablative therapies, which are critical in cancer management, offering less invasive options for patients.
3. Research and Development
- Innovation: A significant focus is placed on R&D, where EDAP TMS invests in developing next-generation technologies and therapies that address unmet medical needs in urology and oncology.
- Clinical Trials: Participation in clinical trials to validate new treatments and technologies is a key aspect of their R&D efforts, aimed at increasing the diversity and efficacy of treatment options available to clinicians.
Products
1. HIFU Systems
- Focal One®: A robotic HIFU platform specifically designed for the treatment of localized prostate cancer. This system enables precise targeting of cancerous tissues while preserving surrounding healthy structures.
- Sonablate®: Another HIFU machine tailored for prostate cancer treatment; it allows for real-time imaging and treatment planning, enhancing the overall therapeutic experience for the patient.
2. Erectile Dysfunction Devices
- EDAP TMS offers solutions aimed at addressing erectile dysfunction, which is a common side effect following conventional prostate cancer treatments. Their products focus on restoring functionality and improving quality of life.
3. Surgical Instruments and Accessories
- The company provides a variety of surgical instruments and specialized accessories to support urological procedures, ensuring that healthcare providers have the tools required for optimal patient care.
4. Software Solutions
- Treatment Planning Software: EDAP TMS has developed advanced software solutions to assist in the diagnosis, treatment planning, and follow-up of patients. These tools incorporate imaging and analytics to facilitate personalized treatment strategies.
Services
1. Training and Support
- EDAP TMS offers extensive training services for healthcare professionals on the use of their technologies and systems. This includes operational training, clinical best practices, and ongoing support to ensure effective utilization of their products.
- Workshops and continuous medical education initiatives are also part of their service offerings, aimed at keeping practitioners updated on the latest technologies and treatment protocols.
2. Clinical Support
- The company provides ongoing clinical support to facilities that utilize their technologies, helping clinicians with case management, patient follow-up, and data collection for continuous improvement in care delivery.
3. Warranty and Maintenance Services
- EDAP TMS includes warranty services for their products, along with maintenance contracts to ensure that the equipment remains in optimal condition, thus maximizing operational efficiency and minimizing downtime.
4. Consultative Services
- Consultants at EDAP TMS work with hospitals and clinics to optimize treatment pathways and integrate their technologies into existing practice protocols, further enhancing patient care.
Global Reach and Market Presence
EDAP TMS operates on an international scale, marketing its products and services to hospitals, outpatient centers, and clinics globally. The company engages in strategic partnerships and collaborations to enhance their market presence and extend their product offerings.
Conclusion
EDAP TMS SA is positioned as a pioneering force in the medical technology space, particularly in urology and oncology. Their commitment to research, innovation, and improving patient outcomes is reflected in their extensive range of products and services, which are tailored to meet the evolving needs of healthcare providers and patients alike. By focusing on minimally invasive techniques and advanced technology, EDAP TMS continues to make significant strides in the field of medical treatment and patient care.